Evidence map›Paper›PMID 36000906›Full record

ArticleMicrobiology spectrum2022

Loop-Mediated Isothermal Amplification Assay for Identifying Neisseria gonorrhoeae Nonmosaic

Ken Shimuta, Hideyuki Takahashi, Yukihiro Akeda, Shu-Ichi Nakayama, Makoto Ohnishi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ken ShimutaDepartment of Bacteriology I, National Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.
Hideyuki TakahashiDepartment of Bacteriology I, National Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.ORCID 0000-0001-8934-8043
Yukihiro AkedaDepartment of Bacteriology I, National Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.
Shu-Ichi NakayamaDepartment of Bacteriology I, National Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.
Makoto OhnishiNational Institute of Infectious Diseasesgrid.410795.e, Tokyo, Japan.
National Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment regimens for gonorrhea have limited efficacy worldwide due to the rapid spread of antimicrobial resistance. Cefixime (CFM) is currently not recommended as a first-line treatment for gonorrhea due to the increasing number of resistant strains worldwide. Nonetheless, Neisseria gonorrhoeae strains can be eradicated by CFM at a 400 mg/day dose, provided that the strains are CFM responsive (MIC ≤ 0.064 mg/L). To develop a nonculture test for predicting the CFM responsiveness of N. gonorrhoeae strains, we developed an assay to detect N. gonorrhoeae nonmosaic

Indexed as

Anti-Infective AgentsGonorrheaAnti-Bacterial AgentsCefiximeCeftriaxoneDrug Resistance, BacterialHumansMicrobial Sensitivity TestsMolecular Diagnostic TechniquesNeisseria gonorrhoeaeNucleic Acid Amplification TechniquesAnti-Bacterial AgentsAnti-Infective AgentsCefiximeCeftriaxonecefiximeloop-mediated isothermal amplificationNeisseria gonorrhoeaepenAsexually transmitted infections

Identifiers

PMID36000906
PMCPMC9602674
OpenAlexW4293213607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.